Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason B Cross

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Computational and Structural Biotechnology Journal|August 21, 2025
Characterization of the KRas G12D-inhibitor interactions by differential HDX-MS and molecular dynamics simulationsEvgeniy V Petrotchenko, Brandon Novy, Edith Nagy, et al.
Journal of Chemical Information and Modeling|May 30, 2009
Comparison of several molecular docking programs: pose prediction and virtual screening accuracyJason B Cross, David C Thompson, Brajesh K Rai, et al.
Analytical Chemistry|September 12, 2025
A Hit Prioritization Strategy for Compound Library Screening Using LiP-MS and Molecular Dynamics Simulations Applied to KRas G12D InhibitorsForoughsadat Absar, Brandon Novy, Edith Nagy, et al.
Journal of Computer-Aided Molecular Design|March 28, 2018
In-silico guided discovery of novel CCR9 antagonistsXin Zhang, Jason B Cross, Jan Romero, et al.
Frontiers in Pharmacology|July 11, 2022
Screening of Hydrocarbon-Stapled Peptides for Inhibition of Calcium-Triggered ExocytosisYing Lai, Michael J Tuvim, Jeremy Leitz, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2016
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrBMichael F Mesleh, Jason B Cross, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
Identification of potent and selective MTH1 inhibitorsAlessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
Journal of Medicinal Chemistry|October 14, 2015
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B InhibitorsJing Zhang, Qingyi Yang, Jason B Cross, et al.
Journal of Medicinal Chemistry|July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral NeuropathyKang Le, Michael J Soth, Jason B Cross, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided DesignJason B Cross, Jing Zhang, Qingyi Yang, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Computational and Structural Biotechnology Journal|August 21, 2025
Characterization of the KRas G12D-inhibitor interactions by differential HDX-MS and molecular dynamics simulationsEvgeniy V Petrotchenko, Brandon Novy, Edith Nagy, et al.
Journal of Chemical Information and Modeling|May 30, 2009
Comparison of several molecular docking programs: pose prediction and virtual screening accuracyJason B Cross, David C Thompson, Brajesh K Rai, et al.
Analytical Chemistry|September 12, 2025
A Hit Prioritization Strategy for Compound Library Screening Using LiP-MS and Molecular Dynamics Simulations Applied to KRas G12D InhibitorsForoughsadat Absar, Brandon Novy, Edith Nagy, et al.
Journal of Computer-Aided Molecular Design|March 28, 2018
In-silico guided discovery of novel CCR9 antagonistsXin Zhang, Jason B Cross, Jan Romero, et al.
Frontiers in Pharmacology|July 11, 2022
Screening of Hydrocarbon-Stapled Peptides for Inhibition of Calcium-Triggered ExocytosisYing Lai, Michael J Tuvim, Jeremy Leitz, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2016
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrBMichael F Mesleh, Jason B Cross, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
Identification of potent and selective MTH1 inhibitorsAlessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
Journal of Medicinal Chemistry|October 14, 2015
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B InhibitorsJing Zhang, Qingyi Yang, Jason B Cross, et al.
Journal of Medicinal Chemistry|July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral NeuropathyKang Le, Michael J Soth, Jason B Cross, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided DesignJason B Cross, Jing Zhang, Qingyi Yang, et al.
Pageof 4